ArticleGE Portuguese journal of gastroenterology2019

Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study.

Marta Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.